The Breakthrough of Technology for Cancer Research – Eric Lefkofsky

Eric Lefkofsky is the founder and CEO of Tempus, a company that informs and educates physicians about scientific breakthroughs in order to keep them better informed when making decisions regarding their patient’s course of cancer treatment. He is an entrepreneur with many business ventures including Groupon, Uptake Technologies, and the Lefkofsky Family Foundation.

Eric Lefkofsky holds a Juris Doctor Degree from the University of Michigan Law School, and prior to that, he completed his undergraduate work at the University of Michigan. He currently works as an adjunct professor at the University of Chicago.In his work with Tempus, Eric partners with prestige hospitals around the country. They collect data that is useful in the ongoing search for a cure for cancer. By providing doctors with software that compares cancer patients DNA, Eric hopes that Tempus will find effective treatments.

In order to concentrate more on Tempus, Eric resigned from his position as CEO of the popular company Groupon. By focusing his efforts on cancer research, he believes that a cure is attainable. By partnering with Brad Keywell, Eric hopes to find business ventures that he has a personal need for and find solutions for problems that affect many.Eric Lefkowsky recognizes that cancer research Center is constantly evolving due to technology. He knows that the research must keep up with our ever-changing world, and he has set out to create a database that will keep up with patients needs as well as provide doctors with information to treat the illness. By comparing patients individual cases, Eric hopes to find new and innovative ways that physicians can provide a course of treatment. Recognizing that each case is unique, it is the hope that together, a cure can be found. Individual treatments are important, as well as an overall cure for this illness.

Leave a Reply

Your email address will not be published. Required fields are marked *